APP and Alzheimer disease: Recently, Schnöder and colleagues11 employed neuron-specific genetic deletion of Mapk14 in an APP (amyloid β [A4] precursor protein)-PS1 (presenillin 1) (APP-PS1) transgenic mouse model for AD and demonstrated increased autophagy and reduced amyloid pathology.